HR 7091119th CongressIn Committee
Expanding Veterans’ Access to Emerging Treatments Act
Standard Summary
Balanced plain-English summary
This bill directs the Secretary of Veterans Affairs to establish an investigational research and extended-access treatment program using innovative treatments and emerging therapies, including psychedelic- and entactogenic-assisted therapies, for veterans with conditions such as chronic pain, PTSD, depression, anxiety, substance use disorders, and traumatic brain injury. It authorizes clinical trials, compassionate or extended access protocols, reporting requirements, and a two-year program review.
Key Points
- 1Requires the VA to develop an investigational research program for innovative treatments and emerging therapies.
- 2Allows VA clinical trials and compassionate or extended access protocols for veterans with unmet medical needs.
- 3Lists covered conditions including chronic pain, PTSD, depression, anxiety, substance use disorders, and traumatic brain injury.
- 4Requires a report to Congress on designated clinics, trial outcomes, safety, efficacy, cost, and regulatory considerations.
- 5Provides for a two-year review during which the VA Secretary may extend or terminate the program.
Impact Areas
VeteransDepartment of Veterans AffairsVA healthcare providersClinical researchersPharmaceutical and medical device developersVeterans service organizations
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026